Navigation Links
ThermoGenesis Announces MXP Involvement in New Regenerative Medicine Initiatives
Date:1/29/2009

PROGRAMS INCLUDE BONE MARROW CLINICAL TRIAL IN ITALY

RANCHO CORDOVA, Calif., Jan. 29 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said today that its MarrowXpress(TM) (MXP(TM)) device is now being used in two new regenerative medicine programs.

These efforts include use of the MXP, which is used to concentrate stem cells from bone marrow, in an ongoing Phase II clinical trial being conducted at the University of Naples in Italy to study the effect of bone marrow derived mononuclear cells on patients with critical limb ischemia (CLI). In addition, ThermoGenesis announced the launch of its distribution agreement with Celling Technologies, an orthopedics company focusing on the cell therapy market.

The University of Naples trial will involve 30 patients and include 12-month follow-up to determine the impact of the treatment. The lead investigators are Dr. Gilda Cobellis and Professor Vincenzo Sica, who has been treating CLI patients with mononuclear cells derived from bone marrow for several years. The early results from his efforts indicate the treatment has resulted in significant improvement in patients' clinical status. The trial in Naples represents the first human use of the ThermoGenesis MXP System for the treatment of CLI patients.

Within one year of being diagnosed with CLI, 40-50 percent of the more than 20 million patients suffering from diabetes in the U.S. will experience a major amputation. The utility of bone marrow derived stem cells to prevent amputation by restoring blood flow to the affected limb is being studied in a number of clinical settings.

"We are pleased that our new MXP System has been selected for this CLI trial with the University of Naples,
'/>"/>

SOURCE ThermoGenesis Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. British Midlands University Announces Use of Gene Technology to Fight Lethal Hospital Acquired Infection
2. Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update
3. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
4. Impact Medical Solutions Announces Appointment of New Director and Corporate Update
5. Oncolytics Biotech Inc. Announces Start of Patient Enrolment in Translational Clinical Trial Investigating REOLYSIN(R) in Patients with Metastatic Colorectal Cancer
6. ISTA Pharmaceuticals Announces Positive Results for Phase IIb Study of Ecabet Sodium
7. Immunomedics Announces Preclinical Therapy Results of SN-38 Immunoconjugate for Colorectal Cancer
8. Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP
9. Kyowa Hakko Kirin Announces Development Policy for Anti-Parkinsons Disease Drug KW-6002 (Istradefylline)
10. Intra-Cellular Therapies Announces Successful Outcome of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia
11. Beactica Announces Fragment-Based Drug Discovery Research Collaboration With GE Healthcare and Uppsala University
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013   Accuray Incorporated (Nasdaq: ... is scheduled to present at the 2013 Jefferies Global ... on Thursday, June 6, 2013 at 1:30 p.m. EDT/10:30 ... presentation will be available online from the Investor Relations ... The webcast replay of the presentation will begin ...
(Date:5/22/2013)... WILMINGTON, Del. and MUNICH , ... venture-backed developer, manufacturer and marketer of transcatheter aortic valve implantation ... today its first interim results of the J enaValve ... Safety I n Pa T ients with S E ... Paris . JUPITER is a post-market registry ...
(Date:5/22/2013)... -- The Lupus Research Institute (LRI) today is hosting the ... lupus nephritis, a serious kidney complication of lupus affecting ... a new international alliance of researchers specializing in lupus ... More than 50 of the world,s top experts ... on two critical questions: 1) Which new medicines have ...
Breaking Medicine Technology:First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 2First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 3First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 4Lupus Research Institute Hosts First International Conference to Advance New Treatments for Lupus Nephritis 2
... DUBLIN, Calif., April 14, 2011 Carl Zeiss ... microscope system at the 79th Annual Meeting of ... Denver, Colo. Based on the breakthrough OPMI® Pentero ... offers innovative new features and customer benefits such ...
... results from the largest multicenter clinical trial for heart ... International Society for Heart & Lung Transplantation (ISHLT) 31st ... show clinical benefit for the use of Everolimus in ... randomized patients at 67 medical centers spanning 5 continents. ...
Cached Medicine Technology:PENTERO 900: Elevating Excellence in Microsurgery to a New Level 2PENTERO 900: Elevating Excellence in Microsurgery to a New Level 3Results From Largest Study of Anti-Rejection Therapy for Heart Transplant Patients Will be Released at ISHLT Meeting 2Results From Largest Study of Anti-Rejection Therapy for Heart Transplant Patients Will be Released at ISHLT Meeting 3Results From Largest Study of Anti-Rejection Therapy for Heart Transplant Patients Will be Released at ISHLT Meeting 4
(Date:5/23/2013)... Platinum Supplemental Insurance recently ... leader. Satterlee started her Platinum sales career in 2011. ... a team of sales representatives selling Platinum products. , ... and residents of rural communities. Satterlee is in charge ... it is help farmers prepare for the future in ...
(Date:5/23/2013)... Teen birth rates declined dramatically in nearly ... data released today by the CDC’s National Center for ... dropped at least 15% in 48 states and declined 30% ... dramatic declines among all racial/ethnic groups as well. Between ... 40% or more for Hispanic teens in 22 states and ...
(Date:5/23/2013)... and Durham, NC (PRWEB) May 23, 2013 ... commercialization firm that funds and develops innovative neurodevice ... Brain Innovations, LLC (DBI). DBI will commercialize ... deep brain stimulation (DBS) therapy for patients with ... effective in treating Parkinson’s disease and generates more ...
(Date:5/23/2013)... known about the human potential to cultivate compassion ... suffering in a way that motivates altruistic behavior. ... for Investigating Healthy Minds at the Waisman Center of ... trained to be more compassionate. The report, recently published ... the first to investigate whether training adults in compassion ...
(Date:5/23/2013)... the networks of connections in the brains of ... has allowed Dr. Peter Williamson, from Western University, ... basis of these important diseases. Dr. Williamson ... specifically in humans, are disrupted in different psychiatric ... 2013 Canadian Neuroscience Meeting, the annual meeting of ...
Breaking Medicine News(10 mins):Health News:Platinum Supplemental Insurance Promotes Mary Satterlee to Sales Team Leader 2Health News:NDI Launches Deep Brain Innovations, LLC 2Health News:NDI Launches Deep Brain Innovations, LLC 3Health News:Study shows people can be trained to be more compassionate 2Health News:Study shows people can be trained to be more compassionate 3Health News:Study shows people can be trained to be more compassionate 4Health News:Researchers identify networks of neurons in the brain that are disrupted in psychiatric disease 2
... Outcome similar to conventional insulin treatment, study shows , ... shock patients, intensive insulin therapy to lower high blood ... risk of death, a new study has found. , ... complication of bacterial infections -- is 60 percent within ...
... Mich. , Jan. 26 National Anesthesia Services is sending ... Anesthesia Relief program and go to Haiti to provide ... February 1st said National president Stephen Read . , "We ... this catastrophe," said Read.  "We have a data base of over 6,000 ...
... , , NASHVILLE, Tenn. , Jan. ... new study ranks its clinical quality among the top five ... row. Saint Thomas Hospital is one of only 269 hospitals ... in Nashville . , The study by HealthGrades, the ...
... , ... Business Intelligence Associates, Inc. (BIA), an information management ... leading provider of scalable, multi-language document repositories for electronic ... and extremely affordable cost shift in the legal document ...
... Governor Mark Sanford was caught red-handed returning from a tryst ... Press that he had met his "soul mate." His choice ... and spiritual connection with Maria Belen Chapur somehow made his ... What the two-timing governor didn,t understand is that most women ...
... ... ... United States Pharmacopeial Convention (USP) will convene a meeting of its member organizations on ... gather to discuss pressing global and domestic public health issues. Known for its large ...
Cached Medicine News:Health News:Intensive Insulin Therapy Won't Boost Septic Shock Survival 2Health News:Staffing Company Sends Anesthesiologists to Haiti 2Health News:Saint Thomas Hospital Ranked Top Five Percent in Nation for the Second Consecutive Year According to Quality Study 2Health News:BIA and Catalyst Release Per-Document Review & Hosting, a Cost-Effective Package 2Health News:BIA and Catalyst Release Per-Document Review & Hosting, a Cost-Effective Package 3Health News:BIA and Catalyst Release Per-Document Review & Hosting, a Cost-Effective Package 4Health News:BIA and Catalyst Release Per-Document Review & Hosting, a Cost-Effective Package 5Health News:BIA and Catalyst Release Per-Document Review & Hosting, a Cost-Effective Package 6Health News:His or hers jealousy? Study offers new explanation for sex differences in jealousy 2Health News:Public Health in Focus at International Conference 2Health News:Public Health in Focus at International Conference 3
At 14 cm point, ruler is bent at 90 degrees angle brought to a blunt point at 15 cm....
Colorado Microneedles offer the surgeon precision in cutting and coagulation, without the expense and inconvenience of a laser. The needles may also be used for dissecting large areas such as the sca...
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Medicine Products: